| An Opportunity Not to be Missed - How do we improve postpartum screening rates for women with gestational diabetes? | |
| | |
MedLine Citation:
|
PMID: 22228674 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The ability to detect postpartum dysglycemia, intervene and prevent type 2 diabetes in this high risk population may be the most compelling reason to diagnose gestational diabetes. However, most studies show less than 50% of women receive any glucose screening in the postpartum period and are thus denied this opportunity. Although many have advocated for simpler testing, the 75 gm oral glucose tolerance test remains the gold standard as a fasting glucose level will miss 30-40% of cases of type 2 diabetes and will not detect isolated impaired glucose tolerance. Hemoglobin A1c as a screening test has not been adequately studied. To improve postpartum screening rates we need to increase awareness of the very high risk of type 2 diabetes, improve communication between providers, reduce fragmentation of care, and introduce system factors that facilitate screening adherence. Copyright © 2012 John Wiley & Sons, Ltd. |
| | |
Authors:
|
Erin Keely |
Related Documents
:
|
12109774 - Antioxidant therapy potentiates antihypertensive action of insulin in diabetic rats. 20957334 - Inhibition of aldehyde dehydrogenase 2 by oxidative stress is associated with cardiac d... 9681924 - Nitric oxide deficiency, leukocyte activation, and resultant ischemia are crucial to th... 16682514 - Effects of diabetes duration and glycemic control on free radicals in children with typ... 3602914 - Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy? 15562474 - Mri of transplanted pancreatic islets. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-6 |
Journal Detail:
|
Title: Diabetes/metabolism research and reviews Volume: - ISSN: 1520-7560 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-9 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100883450 Medline TA: Diabetes Metab Res Rev Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 John Wiley & Sons, Ltd. |
Affiliation:
|
Depts of Medicine and Obstetrics/Gynecology, University of Ottawa; Division of Endocrinology and Metabolism, The Ottawa Hospital, Riverside Campus, 1967 Riverside Dr., Ottawa, On, Canada, K1H7W9. ekeely@toh.on.ca. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Prescriptive contraceptive use among isotretinoin users in the Netherlands in comparison with non-us...
Next Document: Highly Size- and Shape-Controlled Synthesis of Silver Nanoparticles via a Templated Tollens Reaction...